• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

    3/14/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email

    Company achieves 2024 net sales of $186.8 million; up 17% year-over-year

    21st consecutive quarter of year-over-year growth

    Growing consumer interest in probiotic foods with bioavailable nutrients continues to drive strong demand for Lifeway products

    MORTON GROVE, Ill., March 14, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the fourth quarter and full year ended December 31, 2024.

    Lifeway Foods (PRNewsfoto/Lifeway Foods, Inc.)

    "I am pleased to report another record year of net sales for Lifeway, spearheaded by the continued, strong volume growth of our flagship drinkable Lifeway Kefir," commented Julie Smolyansky, President and Chief Executive Officer of Lifeway. "After an extremely successful year in 2023 where we saw sales grow by more than 13%, that growth accelerated in 2024 during which Lifeway delivered further year-over-year growth of 17% to achieve annual net sales of $186.8 million. Our remarkable results were capped off by our second highest-ever quarterly net sales of $46.9 million in the fourth quarter, marking our 21st consecutive quarter of year-over-year growth. This sustained performance underscores the loyalty of our expanding customer base, and the effectiveness of our sales and marketing strategies. We recognize the tailwind from growing consumer interest in protein-rich foods with probiotics and bioavailable nutrients and have meaningfully invested in our core branded offerings to drive trial and accelerate velocities to capture a greater share of that demand. We also regularly evaluate opportunities to elevate the presence of our key branded products through expanded distribution, and were thrilled to announce the recent incremental placements of our Lifeway Farmer Cheese and ProBugs with key accounts. The strategic focus on our branded Lifeway Kefir and Farmer Cheese has delivered robust growth and brand recognition in 2024, and propels us into 2025 with very strong momentum," added Ms. Smolyansky.

    Ms. Smolyansky continued, "The consumer focus on health and wellness continues to grow, and we remain focused on capitalizing on that heightened interest. As we build for the future, I'd like to celebrate the remarkable achievements our team has made in developing a state-of-the-art facility in Waukesha, Wisconsin. We are strategically investing this year to further boost our growth, and our scheduled upgrades at the Waukesha plant will almost double our production capacity and more than triple our bottling speed. We also expect to drive further operational efficiency across the business as we ship higher volumes of our products. To complement our improved production capabilities, we are accelerating our investments behind key product lines to further enhance our market leading position and broaden our brand awareness. 2024 was an excellent year for Lifeway, and I am confident that we are extremely well positioned to deliver another phenomenal performance in 2025."

    Full Year 2024 Results

    Net sales were $186.8 million for the year ended December 31, 2024, an increase of $26.7 million or 16.7% versus prior year. The net sales increase was primarily driven by higher volumes of Lifeway's branded drinkable kefir.

    Gross profit as a percentage of net sales was 26.0% for the year ended December 31, 2024.

    Selling, general and administrative expenses as a percentage of net sales were 18.3% for the year ended December 31, 2024.

    The Company reported net income of $9.0 million or $0.61 per basic and $0.60 per diluted common share for the year ended December 31, 2024.

    We remain confident that the Company is on track to deliver Adjusted EBITDA1 of $45 - $50mm in FY2027. 

    1. Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.

    The Company does not provide guidance for GAAP Operating Income, nor a reconciliation of any forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures on a forward-looking basis, because it is unable to predict certain items contained in the GAAP measures without unreasonable efforts. These forward-looking non-GAAP financial measures do not include certain items, which may be significant, including, without limitation, non-recurring or non-operational expenses such as stock-based compensation, gain/loss on sale of equipment, deferred revenue and gain/loss on investments prior to payment of bonuses to employees.

    Conference Call and Webcast

    A webcast with Lifeway's President and Chief Executive Officer discussing these results with additional comments and details is available through the "Investor Relations" section of the Company's website at https://lifewaykefir.com/webinars-reports/.

    About Lifeway Foods, Inc.

    Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland, South Africa, United Arab Emirates, and France. Learn how Lifeway is good for more than just you at lifewayfoods.com.

    Forward-Looking Statements

    This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the drivers of demand for Lifeway's products, consumer trends, the anticipated effects of scheduled upgrades at the Waukesha plant, expected operating efficiencies and expectations regarding future operating and financial performance. These statements use words, and variations of words, such as "will," "continue," "future," "increase," "believe,"  "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; customer acceptance of products and services; and uncertainty regarding proposals or other actions taken by shareholders related to the unsolicited proposal made by Danone North America PBC ("Danone") to acquire all of the shares of Lifeway stock that Danone does not already own. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.

    Non-GAAP Financial Measures

    This press release refers to Adjusted EBITDA, which is a financial measure that has not been prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"), and may exclude items that are significant to understanding and assessing financial results. This non-GAAP measure is provided to enhance investors' overall understanding of the Company's financial performance. Non-GAAP financial measures should be considered as supplements to GAAP measures reported, should not be considered replacements for, or superior to, GAAP measures reported and may not be comparable to similarly named measures used by other companies. The Company's calculation of non-GAAP financial measures may differ from methods used by other companies.

    Perceptual Advisors

    Dan Tarman

    Email: [email protected]

    Derek Miller 

    Vice President of Communications, Lifeway Foods

    Email: [email protected] 

    General inquiries:

    Lifeway Foods, Inc.

    Phone: 847-967-1010

    Email: [email protected]

     

    LIFEWAY FOODS, INC. AND SUBSIDIARIES

    Unaudited Consolidated Balance Sheets

    December 31, 2024 and 2023

    (In thousands)





















    December 31,







    2024





    2023



    Current assets

















    Cash and cash equivalents



    $

    16,728





    $

    13,198



    Accounts receivable, net of allowance for credit losses and discounts & allowances of

       $1,590 and $1,270 at December 31, 2024 and 2023, respectively





    15,424







    13,875



    Inventories, net





    8,678







    9,104



    Prepaid expenses and other current assets





    2,144







    2,019



    Refundable income taxes





    631







    –



    Total current assets





    43,605







    38,196





















    Property, plant and equipment, net





    26,862







    22,764



    Operating lease right-of use asset





    118







    192



    Goodwill





    11,704







    11,704



    Intangible assets, net





    6,358







    6,898



    Other assets





    1,900







    1,900



    Total assets



    $

    90,547





    $

    81,654





















    Current liabilities

















    Current portion of note payable



    $

    –





    $

    1,250



    Accounts payable





    10,401







    9,976



    Accrued expenses





    5,103







    4,916



    Accrued income taxes





    –







    474



    Total current liabilities





    15,504







    16,616





















    Note payable





    –







    1,483



    Operating lease liabilities





    70







    118



    Deferred income taxes, net





    3,062







    3,001



    Total liabilities





    18,636







    21,218





















    Commitments and contingencies (Note 9)





    –







    –





















    Stockholders' equity

















    Preferred stock, no par value; 2,500 shares authorized; none issued





    –







    –



    Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,100

       and 14,691 shares outstanding at 2024 and 2023





    6,509







    6,509



    Paid-in capital





    4,632







    4,825



    Treasury stock, at cost





    (14,052)







    (16,695)



    Retained earnings





    74,822







    65,797



    Total stockholders' equity





    71,911







    60,436





















    Total liabilities and stockholders' equity



    $

    90,547





    $

    81,654



     

    LIFEWAY FOODS, INC. AND SUBSIDIARIES

    Unaudited Consolidated Statements of Operations

    For the three months and twelve months ended December 31, 2024 and 2023

     (In thousands, except per share data)

     







    Three Months Ended

    December 31,





    Twelve months Ended

    December 31,







    2024





    2023





    2024





    2023





























    Net sales



    $

    46,934





    $

    42,093





    $

    186,820





    $

    160,123





































    Cost of goods sold





    34,273







    29,632







    135,400







    115,060



    Depreciation expense





    764







    669







    2,846







    2,622



    Total cost of goods sold





    35,037







    30,301







    138,246







    117,682





































    Gross profit





    11,897







    11,792







    48,574







    42,441





































    Selling expenses





    3,487







    2,802







    14,743







    11,776



    General and administrative





    7,562







    3,102







    19,439







    13,130



    Amortization expense





    135







    135







    540







    540



    Total operating expenses





    11,184







    6,039







    34,722







    25,446





































    Income from operations





    713







    5,753







    13,852







    16,995





































    Other income (expense):

































    Interest expense





    (3)







    (62)







    (105)







    (384)



    Gain (loss) on sale of property and equipment





    (11)







    1







    (8)







    34



    Other income





    77







    5







    230







    4



    Total other income (expense)





    63







    (56)







    117







    (346)





































    Income before provision for income taxes





    776







    5,697







    13,969







    16,649





































    Provision for income taxes





    936







    1,728







    4,944







    5,282





































    Net income (loss)



    $

    (160)





    $

    3,969





    $

    9,025





    $

    11,367





































    Net earnings (loss) per common share:

































    Basic



    $

    (0.01)





    $

    0.27





    $

    0.61





    $

    0.77



    Diluted



    $

    (0.01)





    $

    0.26





    $

    0.60





    $

    0.75





































    Weighted average common shares outstanding:

































    Basic





    14,857







    14,691







    14,769







    14,667



    Diluted





    15,060







    15,174







    14,956







    15,103



     

    LIFEWAY FOODS, INC. AND SUBSIDIARIES

    Unaudited Consolidated Statements of Cash Flows

    For the Years Ended December 31, 2024 and 2023

    (In thousands)





















    2024





    2023

















    Cash flows from operating activities:

















    Net income



    $

    9,025





    $

    11,367



    Adjustments to reconcile net income to operating cash flow:

















    Depreciation and amortization





    3,386







    3,162



    Non-cash interest expense





    17







    6



    Bad debt expense





    –







    2



    Stock-based compensation





    2,446







    1,497



    Deferred income taxes





    61







    (28)



    Loss (gain) on sale of property and equipment





    8







    (34)



    (Increase) decrease in operating assets:

















    Accounts receivable





    (1,550)







    (2,463)



    Inventories





    426







    527



    Prepaid expenses and other current assets





    (125)







    (574)



    Refundable income taxes





    (631)







    44



    Increase (decrease) in operating liabilities:

















    Accounts payable





    156







    1,859



    Accrued expenses





    217







    1,102



    Accrued income taxes





    (474)







    474



    Net cash provided by operating activities





    12,962







    16,941





















    Cash flows from investing activities:

















    Purchases of property and equipment





    (6,697)







    (4,351)



    Proceeds from sale of equipment





    15







    41



    Purchase of investments





    –







    (100)



    Net cash used in investing activities





    (6,682)







    (4,410)





















    Cash flows from financing activities:

















    Repayment of line of credit





    –







    (2,777)



    Repayment of note payable





    (2,750)







    (1,000)



    Net cash used in financing activities





    (2,750)







    (3,777)





















    Net increase in cash and cash equivalents





    3,530







    8,754



    Cash and cash equivalents at the beginning of the period





    13,198







    4,444



    Cash and cash equivalents at the end of the period



    $

    16,728





    $

    13,198





















    Supplemental cash flow information:

















    Cash paid for income taxes, net of (refunds)



    $

    5,987





    $

    4,792



    Cash paid for interest



    $

    98





    $

    415



    Non-cash investing activities

















    Accrued purchase of property and equipment



    $

    407





    $

    137



    Right-of-use assets obtained in exchange for lease obligations



    $

    –





    $

    94



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-announces-strong-fourth-quarter-and-record-breaking-full-year-2024-results-302401641.html

    SOURCE Lifeway Foods, Inc.

    Get the next $LWAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    9/25/2023Outperform → Market Perform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Edward Smolyansky Rebukes Lifeway Foods (NASDAQ: LWAY) 2024 Amended 10-K Filing

      CHICAGO, May 2, 2025 /PRNewswire/ -- Edward Smolyansky, who together with Ludmila Smolyansky, beneficially own approximately 27% of outstanding shares of Lifeway Foods common stock, today issued the following statement in response to Lifeway's amended 2024 Annual Report and its latest disclosures on executive and director compensation. Apparent Delay of 2025 Annual Meeting of Shareholders On March 13, Edward Smolyansky submitted a full slate of Board nominees for Lifeway's 2025 Annual Meeting. To date, Lifeway has yet to file a preliminary or definitive proxy statement setting forth its own slate. "The filing of the amended 2024 Annual Report, and other steps taken recently by the Company,

      5/2/25 12:50:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lifeway Foods downgraded by Noble Capital Markets

      Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

      9/24/24 8:32:49 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods upgraded by Noble Capital Markets with a new price target

      Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

      5/30/24 9:15:56 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lake Street initiated coverage on Lifeway Foods with a new price target

      Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00

      4/5/24 8:42:53 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 4:33:49 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 8:53:57 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      9/23/24 4:07:26 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Lifeway Foods Inc.

      10-Q - Lifeway Foods, Inc. (0000814586) (Filer)

      5/13/25 9:00:23 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 6:46:02 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form 10-K/A filed by Lifeway Foods Inc.

      10-K/A - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 4:15:08 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO, President and Secretary Smolyansky Julie sold $1,103,500 worth of shares (50,000 units at $22.07), decreasing direct ownership by 2% to 2,132,483 units (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/20/25 3:12:39 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $891,927 worth of shares (37,482 units at $23.80) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/5/25 4:50:03 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $487,769 worth of shares (20,518 units at $23.77) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/1/25 5:01:56 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Financials

    Live finance-specific insights

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

      Company achieves 2024 net sales of $186.8 million; up 17% year-over-year 21st consecutive quarter of year-over-year growth Growing consumer interest in probiotic foods with bioavailable nutrients continues to drive strong demand for Lifeway products MORTON GROVE, Ill., March 14, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the fourth quarter and full year ended December 31, 2024. "I am pleased to report another reco

      3/14/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples